UniDoc Health Corp.

UniDoc Health Corp.

0.11
CAD
-0.07
(-38.89%)
-0.04EPS
15.54MMarket Cap
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
0.01
Basic EPS, GAAP
- -
-0.09
-0.03
-0.04
-0.11
-0.04
Free Cash Flow per Basic Share
- -
-0.07
-0.02
-0.01
-0.14
-0.04
Dividend per Share
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
0.01
-0.02
-0.03
0.01
- -
Tangible Book Value per Share
- -
0.01
-0.02
-0.03
- -
-0.01
Basic Weighted Avg Shares
85
34
44
50
56
78
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
1
Operating Margin (%)
- -
- -
- -
- -
- -
-408.61
Depreciation Expense
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-3
-1
-2
-6
-3
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
-447.2
Working Capital
- -
- -
-1
-2
- -
-1
LT Debt
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
-1
-2
1
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -

Capital Structure

CAD

•

in mil. unless spec.
Jun'26
Sep'26
Dec'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
76
76
86
Market Capitalization
14
14
16

Working Capital

CAD

•

in mil. unless spec.
Jun'26
Sep'26
Dec'26
Total Current Assets
2
1
1
Cash, Cash Equivalents & STI
1
- -
1
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
2
3
2
Payables & Accruals
2
2
2
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

CAD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-135.66%
Free Cash Flow
- -
- -
1,267.24%
Net Income, GAAP
- -
- -
168.31%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.02
-0.01
-0.01
-0.01
-0.04
2025
-0.05
-0.03
-0.02
-0.01
-0.11
2026
-0.01
-0.01
-0.01
- -
- -

Quarterly Dividends Per Share

CAD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Antonio Baldassarre
Full Time Employees
5
Sector
Health services
Industry
Medical/Nursing services
Address
81 Zenway Blvd. Vaughan ON Canada L4H 0S5
IPO Date
Dec 13, 2021
Business
Unidoc Health Corp. is a healthcare technology company specializing in cloud-based telemedicine platforms and medical data management solutions primarily for healthcare providers and patients in Canada and internationally. The company offers advanced telehealth software products that enable virtual consultations; digital patient management systems; medical record integration tools; and healthcare analytics services designed to improve clinical efficiency and patient outcomes. Unidoc Health also provides associated consulting services and technical support to healthcare institutions and practitioners. Founded in 2018 and headquartered in Toronto, Ontario, Unidoc Health operates in the healthcare IT and telemedicine industry segments, targeting medical institutions, clinics, and independent healthcare professionals. In the past two years, the company has made significant strategic advancements including launching new telehealth service offerings that leverage AI-driven diagnostics, and entering into strategic partnerships with key medical device manufacturers to enhance telemedicine capabilities. Additionally, Unidoc Health has expanded its market presence through acquisitions of regional healthcare software firms, strengthening its technology stack and broadening customer reach. The company’s product suite includes its flagship telemedicine platform marketed under the Unidoc brand, cloud-based electronic health record (EHR) solutions, online appointment scheduling systems, and patient engagement portals. These offerings facilitate virtual care delivery, remote patient monitoring, and seamless integration with existing healthcare IT infrastructures. The recent addition of AI-based symptom triage and diagnostic tools as part of its product evolution marks a major service enhancement positioning Unidoc Health as an innovative leader in telehealth technologies within North America and select international markets. Unidoc Health’s continuous innovation and growth strategy align with the rising demand for accessible digital healthcare solutions. The company’s operations remain focused on expanding its technology capabilities, strategic collaborations, and market footprint to support the evolving needs of healthcare providers and patients globally while maintaining a strong Canadian operational base.

Company News

  • UniDoc Health Equips San Juan, Puerto Rico Ambulances With Live Patient Video

  • UniDoc Health Signs MOU with Ventripoint Diagnostics to Evaluate Remote Cardiac Assessment and Screening Platform

  • UniDoc Connect Surpasses One Million Patient Visits

  • UniDoc Reflects on Successes One Year After AMD Telemedicine Software Purchase

  • UniDoc to Update and Relaunch Legacy eHealth Systems with Pawnee Mental Health Services Across Rural Kansas

  • UniDoc Completes H3 Health Cube Installation in Italy

  • UniDoc Receives Order for Health Cubes

  • UniDoc to Exhibit at ANCI 2025 in Bologna, November 12-14

  • UniDoc Closes Fully Subscribed LIFE Offering

  • UniDoc Announces Amended LIFE Offering

  • RETRANSMISSION UniDoc Announces LIFE Offering

  • UniDoc Announces LIFE Offering

  • UniDoc Health Corp. Provides Corporate Update

  • UniDoc Health Corp. to Participate in Ukraine Recovery Conference (URC2025)

  • UniDoc Provides Update on Marketing Engagement

  • UniDoc Announces Debt Settlement and Renews Marketing Engagement

  • UniDoc Completes Purchase of AGNES Connect(R) Software from AMD Telemedicine

  • UniDoc Announces Purchase Agreement for AGNES Connect Software from AMD Telemedicine

  • UniDoc - Announces Filing of Amended and Restated Interim Management Discussion and Analysis

  • UniDoc - Company Recognizes Initial Revenue on Delivery of AI-Equipped H3 Health Cubes